BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 30 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,607 | -53.2% | 13,962 | +2.0% | 0.00% | – |
| Q4 2022 | $9,852 | -1.5% | 13,683 | +57.8% | 0.00% | – |
| Q3 2022 | $10,000 | -16.7% | 8,670 | -13.7% | 0.00% | – |
| Q2 2022 | $12,000 | -45.5% | 10,048 | -2.8% | 0.00% | – |
| Q1 2022 | $22,000 | +175.0% | 10,335 | +84.0% | 0.00% | – |
| Q4 2021 | $8,000 | -50.0% | 5,618 | -0.0% | 0.00% | – |
| Q3 2021 | $16,000 | 0.0% | 5,619 | +16.7% | 0.00% | – |
| Q2 2021 | $16,000 | +433.3% | 4,816 | +460.0% | 0.00% | – |
| Q1 2021 | $3,000 | -72.7% | 860 | -71.9% | 0.00% | – |
| Q4 2020 | $11,000 | -45.0% | 3,061 | -1.0% | 0.00% | – |
| Q3 2020 | $20,000 | +185.7% | 3,093 | +223.9% | 0.00% | – |
| Q2 2020 | $7,000 | -94.0% | 955 | -96.1% | 0.00% | – |
| Q1 2020 | $116,000 | – | 24,725 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 448,101 | $537,000 | 0.11% |
| Long Focus Capital Management, LLC | 327,692 | $393,000 | 0.04% |
| Boxer Capital, LLC | 56,950 | $68,000 | 0.00% |
| SHUFRO ROSE & CO LLC | 12,941 | $16,000 | 0.00% |
| Baker Brothers Advisors | 249,123 | $299,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 45,057 | $54,000 | 0.00% |
| Orion Capital Management LLC | 500 | $1,000 | 0.00% |
| Parallel Advisors, LLC | 10 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 779 | $1,000 | 0.00% |
| NORTHERN TRUST CORP | 10,981 | $13,000 | 0.00% |